|
1
|
Salomon-Perzyński A, Salomon-Perzyńska M,
Michalski B and Skrzypulec-Plinta V: High-grade serous ovarian
cancer: The clone wars. Arch Gynecol Obstet. 295:569–576. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramachandran SM, Liu LY and Perkins SH:
Peristomal nodule patient with ovarian cancer. JAMA. 319:1158–1159.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gallotta V, Cicero C, Conte C, Vizzielli
G, Petrillo M, Fagotti A, Chiantera V, Costantini B, Scambia G and
Ferrandina G: Robotic versus laparoscopic staging for early ovarian
cancer: A case-matched control study. J Minim Invasive Gynecol.
24:293–298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong H, Zhang Y and Xi H: The effects of
epidural anaesthesia and analgesia on natural killer cell
cytotoxicity and cytokine response in patients with epithelial
ovarian cancer undergoing radical resection. J Int Med Res.
40:1822–1829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schaller SJ, Alam SM, Mao J, Zhao Y,
Blobner M, Greenblatt DJ and Martyn JA: Pharmacokinetics cannot
explain the increased effective dose requirement for morphine and
midazolam in rats during their extended administration alone or in
combination. J Pharm Pharmacol. 69:82–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Armstrong DK: New therapies for ovarian
cancer. J Natl Compr Canc Netw 16 (5S). 632–635. 2018. View Article : Google Scholar
|
|
7
|
Park SJ, Shin S, Kim SH, Kim HW, Kim SH,
Do HY and Choi YS: Comparison of dexmedetomidine and fentanyl as an
adjuvant to ropivacaine for postoperative epidural analgesia in
pediatric orthopedic surgery. Yonsei Med J. 58:650–657. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scibelli G, Maio L, Sasso M, Lanza A and
Savoia G: Dexmedetomidine: Current role in burn ICU. Transl Med
UniSa. 16:1–10. 2017.PubMed/NCBI
|
|
9
|
Pudenz M, Roth K and Gerhauser C: Impact
of soy isoflavones on the epigenome in cancer prevention.
Nutrients. 6:4218–4272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicula R and Costin N: Management of
endometrial modifications in perimenopausal women. Clujul Med.
88:101–110. 2015.PubMed/NCBI
|
|
11
|
Chatterjee M, Hurley LC and Tainsky MA:
Paraneoplastic antigens as biomarkers for early diagnosis of
ovarian cancer. Gynecol Oncol Rep. 21:37–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Felix AS, Bower JK, Pfeiffer RM, Raman SV,
Cohn DE and Sherman ME: High cardiovascular disease mortality after
endometrial cancer diagnosis: Results from the Surveillance,
Epidemiology, and End Results (SEER) Database. Int J Cancer.
140:555–564. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zambirinis CP and Miller G: Cancer
manipulation of host physiology: Lessons from pancreatic cncer.
Trends Mol Med. 23:465–481. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brand AH, DiSilvestro PA, Sehouli J and
Berek JS: Cytoreductive surgery for ovarian cancer: Quality
assessment. Ann Oncol. 28 (Suppl 8):viii25–viii29. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghodki PS, Sardesai SP and Halikar SS:
Dexmedetomidine premedication in cataract surgery under topical
anaesthesia: To assess patient and surgeon satisfaction. S Afr J
Anaesthesiol Analg. 21:17–21. 2015.
|
|
16
|
Djaiani G, Silverton N, Fedorko L, Carroll
J, Styra R, Rao V and Katznelson R: Dexmedetomidine versus propofol
sedation reduces delirium after cardiac surgery: A randomized
controlled trial. Anesthesiology. 124:362–368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Balk M, Hentschke H, Rudolph U, Antkowiak
B and Drexler B: Differential depression of neuronal network
activity by midazolam and its main metabolite 1-hydroxymidazolam in
cultured neocortical slices. Sci Rep. 7:3503–3515. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yasoshima Y and Shimura T: Midazolam
impairs the retrieval of conditioned taste aversion via opioidergic
transmission in mice. Neurosci Lett. 636:64–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Freeman J and Buggy DJ: Modelling the
effects of perioperative interventions on cancer outcome: Lessons
from dexmedetomidine. Br J Anaesth. 120:15–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Z and Sheng L: Significance of dynamic
evolution of TNF-α, IL-6 and intestinal fatty acid-binding protein
levels in neonatal necrotizing enterocolitis. Exp Ther Med.
15:1289–1292. 2018.PubMed/NCBI
|
|
21
|
Kim Y, Lim HJ, Jang HJ, Lee S, Jung K, Lee
SW, Lee SJ and Rho MC: Portulaca oleracea extracts and their active
compounds ameliorate inflammatory bowel diseases in vitro and in
vivo by modulating TNF-α, IL-6 and IL-1β signalling. Food Res Int.
106:335–343. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta B, Verma RK, Kumar S and Chaudhary
G: Comparison of analgesic efficacy of dexmedetomidine and
midazolam as adjuncts to lignocaine for intravenous regional
anesthesia. Anesth Essays Res. 11:62–66. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barends CR, Absalom A, van Minnen B,
Vissink A and Visser A: Dexmedetomidine versus midazolam in
procedural sedation. A systematic review of efficacy and safety.
PLoS One. 12:e01695252017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Field C and Goff BA: Dermatomyositis - key
to diagnosing ovarian cancer, monitoring treatment and detecting
recurrent disease: Case report. Gynecol Oncol Rep. 23:1–3. 2017.
View Article : Google Scholar : PubMed/NCBI
|
